MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Umbach, J. A.
Right arrow Articles by Gundersen, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Umbach, J. A.
Right arrow Articles by Gundersen, C. B.

Mercuric ions are potent noncompetitive antagonists of human brain kainate receptors expressed in Xenopus oocytes

JA Umbach and CB Gundersen

Department of Pharmacology, University of California, Los Angeles School of Medicine 90024-1735.

Kainate receptors are one of the major subtypes of excitatory amino acid receptors in the vertebrate central nervous system. Using Xenopus oocytes injected with RNA from human temporal cortex, it is possible to detect electrophysiologically the expression of this receptor subtype in these cells. Ions of the group IIb elements, particularly mercuric ions, are highly potent, noncompetitive inhibitors of these human brain kainate receptors. Mercury-containing sulfhydryl reagents are also very effective, irreversible blockers of the kainate-gated currents of these oocytes. The recovery of kainate-activated currents after washout of Hg2+ is slow and incomplete relative to that seen after treatment either with Cd2+ or Zn2+. Cysteine or dithiothreitol can accelerate this recovery of kainate-inducible currents after Hg2+ inhibition. Besides the toxicological implications of these results, mercury compounds may be useful for future studies of the structure and physiology of the kainate receptor-channel complex.

Volume 36, Issue 4, pp. 582-588, 10/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
R. Miledi, Z. Duenas, A. Martinez-Torres, C. H. Kawas, and F. Eusebi
From The Cover: Microtransplantation of functional receptors and channels from the Alzheimer's brain to frog oocytes
PNAS, February 10, 2004; 101(6): 1760 - 1763.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. Palma, V. Esposito, A. M. Mileo, G. Di Gennaro, P. Quarato, F. Giangaspero, C. Scoppetta, P. Onorati, F. Trettel, R. Miledi, et al.
Expression of human epileptic temporal lobe neurotransmitter receptors in Xenopus oocytes: An innovative approach to study epilepsy
PNAS, November 12, 2002; 99(23): 15078 - 15083.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. Mirzoian and C. W. Luetje
Modulation of Neuronal Nicotinic Acetylcholine Receptors by Mercury
J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 560 - 567.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
D. Bowie
External anions and cations distinguish between AMPA and kainate receptor gating mechanisms
J. Physiol., March 15, 2002; 539(3): 725 - 733.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1989 by the American Society for Pharmacology and Experimental Therapeutics